Are there potential problems with generic substitution of antiepileptic drugs?

This publication has 53 references indexed in Scilit:

• BIO-AVAILABILITY AND DISSOLUTION OF THREE PHENYTOIN PREPARATIONS FOR CHILDREN
  Developmental Medicine and Child Neurology, 2008
• The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs
  Clinical Therapeutics, 2003
• Effects of Switching From Depakene to Generic Valproic Acid on Individuals With Mental Retardation
  Mental Retardation, 1997
• Generic Drugs
  Drug Safety, 1996
• Bioavailability and dissolution of proprietary and generic formulations of phenytoin.
  Journal of Neurology, Neurosurgery & Psychiatry, 1992
• Comparison on Bioequivalence of Four Phenytoin Preparations in Patients with Multiple‐Dose Treatment
  The Journal of Clinical Pharmacology, 1992
• GENERIC VERSUS BRANDED CARBAMAZEPINE
  The Lancet, 1987
• Generic Equivalents: Issues and Concerns
  The Journal of Clinical Pharmacology, 1986
• A comparative study of the bioavailability of five different phenytoin preparations
  Journal of Pharmacy and Pharmacology, 1985
• Comparative Bioavailability of Phenytoin from Generic Formulations in the United Kingdom
  Epilepsia, 1982